Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension
- Registration Number
- NCT02426177
- Lead Sponsor
- Dow University of Health Sciences
- Brief Summary
To compare effectiveness of oral labetalol and oral nifedipine for management of postpartum hypertension.
- Detailed Description
A comparison of oral labetalol and oral nifedipine for management of postpartum hypertension. Which drug is more effective in lowering blood pressures in patient with postpartum hypertension.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 98
Inclusion Criteria
- all women with postpartum hypertension as a continuation of pregnancy induced hypertension,eclampsia, pre-eclampsia or new onset de-novo postpartum hypertension,of any parity.
- age group between 18-48.
- after informed consent.
Exclusion Criteria
- all women with chronic hypertension, uncontrolled and un treated medical disorders will be excluded.
- conditions in which drugs labetalol and nifedipine is contraindicated.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description group A Labetalol tab.labetalol is given to the patient with postpartum hypertension in dose of 100 mg 6 hourly increased to maximum 600 mg in 24 hours group B Nifedipine tab.nifedipine is given to the patient with postpartum hypertension in the dose of 10 mg twice a day to maximum dose of 60 mg per 24 hours
- Primary Outcome Measures
Name Time Method Blood Pressure less than 140/90 mm of hg 24 hours less than 140/90 mm of hg
- Secondary Outcome Measures
Name Time Method